| ROTA-biotic: Measuring the Impact of Rotavirus Vaccines on Paediatric Antibiotic Usage (NCT06882070) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2021-05-04 |
| Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates (NCT04185545) | PT Bio Farma | 2020-10-30 |
| Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac in Healthy Infants in Vietnam (NCT04596696) | Bharat Biotech International Limited | 2017-12-20 |
| Study on Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) to Evaluate Lot-to-Lot Consistency and to Compare Non-Inferiority With ROTASIIL (Lyophilized BRV-PV) in Healthy Infants in India (NCT03474055) | Serum Institute of India Pvt. Ltd. | 2017-10-30 |
| Safety, Reactogenicity and Immunogenicity of Heat-stable Rotavirus Vaccine (HSRV) in Adults and Infants (NCT02728869) | MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd. | 2016-06-01 |
| Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization (NCT02584816) | Serum Institute of India Pvt. Ltd. | 2015-11-01 |
| To Determine the Safety and Efficacy of Liquid ROTAVAC 5C Vaccine Against Childhood Diarrhea Caused by Rotavirus (NCT04819412) | Bharat Biotech International Limited | 2015-03-20 |
| Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024) (NCT02062385) | Merck Sharp & Dohme LLC | 2014-05-30 |
| A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants (NCT02133690) | Serum Institute of India Pvt. Ltd. | 2014-05-01 |
| A Study of the Immunogenicity, Tolerability, and Safety of a New Formulation of RotaTeq™ in Infants (V260-035) (NCT01600092) | Merck Sharp & Dohme LLC | 2013-04-29 |
| Enteroadsorbent Polymethylsiloxane vs Probiotic Lactobacillus Reuteri in the Treatment of Rotaviral Gastroenteritis (NCT04116307) | University Hospital for Infectious Diseases, Croatia | 2013-01-01 |
| Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana (NCT01575197) | PATH | 2012-09-01 |
| Immunogenicity of Rotavirus Vaccine (NCT01199874) | PATH | 2011-04-01 |
| Community Based Prevention of Rotavirus Gastroenteritis by a Functional Food Supplement (NCT01265355) | Christian Medical College, Vellore, India | 2011-03-01 |
| Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia (NCT01236066) | GlaxoSmithKline | 2010-10-01 |
| A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in Japan (NCT01202201) | GlaxoSmithKline | 2010-09-01 |
| A Study to Evaluate the Safety of Tetravalent Rotavirus Vaccine in Healthy Indian Adult Male Volunteers (NCT01091298) | Shantha Biotechnics Limited | 2010-04-01 |
| A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN) (NCT01003431) | Merck Sharp & Dohme LLC | 2009-12-01 |
| A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED) (NCT00953056) | Merck Sharp & Dohme LLC | 2009-09-01 |
| Rotavirus Gastroenteritis and Vaccine Usage in Rhode Island (NCT01026779) | Lifespan | 2009-07-01 |
| Epidemiology of Rotavirus Infection in North India Community (NCT01508533) | Society for Applied Studies | 2009-07-01 |
| Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab (NCT00737503) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2008-09-01 |
| Estimation of the Burden of Rotavirus Gastroenteritis (RV GE) in Children Less Than 5 Years in Greece (NCT00751686) | GlaxoSmithKline | 2008-07-01 |
| Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden (NCT00489567) | GlaxoSmithKline | 2007-10-01 |
| Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France. (NCT00740935) | University Hospital, Brest | 2007-05-01 |
| Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants (NCT00169455) | GlaxoSmithKline | 2005-03-01 |